Neha Nanda, MD

Clinical Professor of Medicine (Clinician Educator), Hospital Epidemiologist and Medical Director of Antimicrobial Stewardship at Keck Medicine of USC, Chief of Infectious Diseases

Image of Neha Nanda, MD
Is this your profile? Click to edit

Overview

Dr. Nanda heads Healthcare Epidemiology/Infection Prevention and Antimicrobial Stewardship at Keck Medicine of USC and its affiliated hospitals and clinics. In this capacity, she leads Keck Medicine’s preparation and response for emerging infectious disease. In the last year, through the pandemic, she has led protocol and guideline development as it relates to patient and healthcare safety. Her research interests are geared towards infection prevention strategies and emerging pathogens. Her select publications include the impact of a multidisciplinary approach in reducing preventable harm, treatment strategies and diagnostics for C. difficile and biomarkers for appropriate antimicrobial use.

Awards

  • Society of Healthcare and Epidemiology of America: Jonathan Freeman Scholarship for Excellence in Healthcare Epidemiology Research, 2007
  • Yale University: William Wirt Winchester Research Fund Award for Tuberculosis Research, 2007
  • Yale University: Yale Infectious Diseases Collaborative Fund, 2007
  • Waterbury Hospital: In the Spotlight Award for Recognition of Efforts for Ebola Preparedness, 2015

Publications

  • Cell-free DNA metagenomic next generation sequencing for the diagnosis of infectious diseases: a retrospective assessment of clinical utility in a tertiary and quaternary care facility. Front Microbiol. 2026; 17:1879762.. View in PubMed
  • Evogliptin prevents ceramide-induced pyroptosis during calcification via modulation of NLRP3/GSDM-D mediated pathway in Vascular Smooth Muscle Cells. PLoS One. 2025; 20(12):e0337200.. View in PubMed
  • Long COVID: A Systematic Review of Preventive Strategies. Infect Dis Rep. 2025 May 21; 17(3).. View in PubMed
  • Somatic loss of ATM is a late event in pancreatic tumorigenesis. J Pathol. 2023 08; 260(4):455-464.. View in PubMed
  • Tixagevimab-Cilgavimab: Utilization in the solid organ transplant population. Clin Transplant. 2022 06; 36(6):e14661.. View in PubMed
  • Functional CDKN2A assay identifies frequent deleterious alleles misclassified as variants of uncertain significance. Elife. 2022 01 10; 11.. View in PubMed
  • Predicting clinical outcomes in COVID-19 using radiomics on chest radiographs. Br J Radiol. 2021 Oct 01; 94(1126):20210221.. View in PubMed
  • The time to offer treatments for COVID-19. Expert Opin Investig Drugs. 2021 May; 30(5):505-518.. View in PubMed
  • Examination of ATM, BRCA1, and BRCA2 promoter methylation in patients with pancreatic cancer. Pancreatology. 2021 Aug; 21(5):938-941.. View in PubMed
  • Machine learning based predictors for COVID-19 disease severity. Sci Rep. 2021 02 25; 11(1):4673.. View in PubMed